Rockwell Medical, Inc. (RMTI): Price and Financial Metrics
GET POWR RATINGS... FREE!
RMTI Stock Summary
- With a market capitalization of $15,471,455, ROCKWELL MEDICAL INC has a greater market value than just 6.5% of US stocks.
- The capital turnover (annual revenue relative to shareholder's equity) for RMTI is 4.27 -- better than 88.87% of US stocks.
- With a price/sales ratio of 0.22, ROCKWELL MEDICAL INC has a higher such ratio than only 7.49% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to ROCKWELL MEDICAL INC, a group of peers worth examining would be BC, BODY, EFOI, OB, and SHYF.
- RMTI's SEC filings can be seen here. And to visit ROCKWELL MEDICAL INC's official web site, go to www.rockwellmed.com.
RMTI Valuation Summary
- In comparison to the median Healthcare stock, RMTI's EV/EBIT ratio is 116.79% lower, now standing at -1.1.
- RMTI's price/sales ratio has moved down 0.8 over the prior 243 months.
Below are key valuation metrics over time for RMTI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| RMTI | 2023-03-17 | 0.2 | 1.0 | -0.6 | -1.1 |
| RMTI | 2023-03-16 | 0.2 | 1.0 | -0.6 | -1.1 |
| RMTI | 2023-03-15 | 0.2 | 0.9 | -0.6 | -1.0 |
| RMTI | 2023-03-14 | 0.2 | 1.0 | -0.6 | -1.1 |
| RMTI | 2023-03-13 | 0.2 | 1.0 | -0.6 | -1.1 |
| RMTI | 2023-03-10 | 0.2 | 1.0 | -0.7 | -1.1 |
RMTI Growth Metrics
- Its 4 year price growth rate is now at -67.86%.
- Its 2 year net cashflow from operations growth rate is now at -8.75%.
- Its 4 year net income to common stockholders growth rate is now at -69.53%.
The table below shows RMTI's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 68.829 | -25.846 | -25.26 |
| 2022-06-30 | 66.126 | -31.819 | -28.651 |
| 2022-03-31 | 62.581 | -30.851 | -32.084 |
| 2021-12-31 | 61.931 | -33.534 | -32.674 |
| 2021-09-30 | 61.762 | -33.077 | -32.396 |
| 2021-06-30 | 61.054 | -30.91971 | -32.165 |
RMTI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- RMTI has a Quality Grade of D, ranking ahead of 9.74% of graded US stocks.
- RMTI's asset turnover comes in at 0.825 -- ranking 30th of 681 Pharmaceutical Products stocks.
- IMGN, PTE, and BCDA are the stocks whose asset turnover ratios are most correlated with RMTI.
The table below shows RMTI's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.825 | 0.014 | -0.801 |
| 2021-03-31 | 0.850 | 0.033 | -0.675 |
| 2020-12-31 | 0.863 | 0.044 | -0.730 |
| 2020-09-30 | 0.981 | 0.055 | -0.790 |
| 2020-06-30 | 1.151 | 0.049 | -0.908 |
| 2020-03-31 | 1.139 | 0.048 | -1.191 |
RMTI Price Target
For more insight on analysts targets of RMTI, see our RMTI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $5.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
RMTI Stock Price Chart Interactive Chart >
RMTI Price/Volume Stats
| Current price | $1.40 | 52-week high | $5.50 |
| Prev. close | $1.38 | 52-week low | $0.84 |
| Day low | $1.36 | Volume | 120,500 |
| Day high | $1.45 | Avg. volume | 328,181 |
| 50-day MA | $1.80 | Dividend yield | N/A |
| 200-day MA | $1.43 | Market Cap | 13.17M |
Rockwell Medical, Inc. (RMTI) Company Bio
Rockwell Medical is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. The company was founded in 1995 and is based in Wixom, Michigan.
Latest RMTI News From Around the Web
Below are the latest news stories about ROCKWELL MEDICAL INC that investors may wish to consider to help them evaluate RMTI as an investment opportunity.
Rockwell Medical Named 'Great Place to Work'WIXOM, Mich., February 28, 2023--Rockwell Medical has been certified as a Great Place to Work in 2023, the Company's inaugural year participating in the accreditation. |
Rockwell Medical to Release Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30, 2023WIXOM, Mich., February 16, 2023--Rockwell Medical to Release Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30, 2023. |
Beat the Market Like Zacks: NVIDIA, Boeing, Rockwell Medical in FocusOur time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months. |
Rockwell Medical and Concerto Renal Services Establish New Three-Year, Multi-Million Dollar Product Purchase AgreementWIXOM, Mich., February 13, 2023--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company signed a three-year product purchase agreement with Concerto Renal Services ("Concerto"), the largest provider of dialysis in skilled nursing facilities in the United States. Under the terms of the agreement, Rockwell Medi |
Rockwell Medical Signs Three-Year, Multi-Million Dollar Supply Agreement with Largest Non-Profit Dialysis Provider in the United StatesWIXOM, Mich., February 02, 2023--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company signed a three-year, multi-million dollar per annum product purchase agreement with the largest non-profit dialysis provider in the United States. As part of the agreement, Rockwell Medical will be the preferred supplier o |
RMTI Price Returns
| 1-mo | -37.50% |
| 3-mo | 44.33% |
| 6-mo | 10.24% |
| 1-year | -66.42% |
| 3-year | -94.81% |
| 5-year | -97.59% |
| YTD | 37.93% |
| 2022 | -77.49% |
| 2021 | -59.41% |
| 2020 | -58.61% |
| 2019 | 7.96% |
| 2018 | -61.17% |
Continue Researching RMTI
Want to do more research on Rockwell Medical Inc's stock and its price? Try the links below:Rockwell Medical Inc (RMTI) Stock Price | Nasdaq
Rockwell Medical Inc (RMTI) Stock Quote, History and News - Yahoo Finance
Rockwell Medical Inc (RMTI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...